CVE-2026-84856rowboatlabs rowboat Composio Webhook Endpoint route.ts req.json denial of service
Updated under an hour ago ()
Does this affect you?
It affects rowboatlabs rowboat. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
A vulnerability was detected in rowboatlabs rowboat up to 0.9.1. The impacted element is the function request.text/req.json of the file apps/rowboat/app/api/composio/webhook/route.ts of the component Composio Webhook Endpoint. The manipulation results in denial of service. It is possible to launch the attack remotely. The exploit is now public and may be used. Upgrading to version 0.9.2 is sufficient to resolve this issue. Upgrading the affected component is recommended. The legacy Next.js app was deleted at 0.9.2 rather than patched, leaving no security control behind.
- CVSS
- 5.3 MEDIUM (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:L/E:P/RL:O/RC:C
- Weakness (CWE)
- CWE-404
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- VulDB
- NVD analysis
- Deferred
- Record last updated
- Sep 3, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
rowboatlabs rowboat rowboatlabs:rowboat | 0.9.0; 0.9.1; 0.9.2 not affected | CNA record |
References
- https://vuldb.com/vuln/398131vdb-entry, technical-description
- https://vuldb.com/vuln/398131/ctisignature, permissions-required
- https://vuldb.com/cve/CVE-2026-84856third-party-advisory
- https://vuldb.com/submit/886260third-party-advisory
- https://github.com/hackerguopeng/cve/tree/main/Rowboat_PreAuth_Body_Buffer_DoS_Reportexploit
- https://github.com/rowboatlabs/rowboat/releases/tag/v0.9.2patch
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.